Cibc World Market Inc. Grows Position in Albemarle Corporation $ALB

Cibc World Market Inc. grew its position in shares of Albemarle Corporation (NYSE:ALB) by 24.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 38,476 shares of the specialty chemicals company’s stock after purchasing an additional 7,542 shares during the quarter. Cibc World Market Inc.’s holdings in Albemarle were worth $3,120,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. AQR Capital Management LLC raised its position in shares of Albemarle by 25.5% in the first quarter. AQR Capital Management LLC now owns 3,223 shares of the specialty chemicals company’s stock worth $229,000 after acquiring an additional 654 shares during the period. Integrated Wealth Concepts LLC increased its stake in shares of Albemarle by 26.2% in the 1st quarter. Integrated Wealth Concepts LLC now owns 4,798 shares of the specialty chemicals company’s stock valued at $346,000 after purchasing an additional 996 shares in the last quarter. United Services Automobile Association acquired a new position in Albemarle in the 1st quarter worth about $208,000. Empowered Funds LLC purchased a new position in Albemarle during the first quarter worth approximately $411,000. Finally, Concurrent Investment Advisors LLC grew its holdings in Albemarle by 25.7% in the second quarter. Concurrent Investment Advisors LLC now owns 4,724 shares of the specialty chemicals company’s stock valued at $296,000 after purchasing an additional 965 shares during the period. 92.87% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on ALB shares. Truist Financial upgraded Albemarle from a “hold” rating to a “buy” rating and increased their target price for the company from $125.00 to $205.00 in a research report on Wednesday, January 21st. Dbs Bank upped their price objective on shares of Albemarle from $100.00 to $120.00 and gave the stock a “buy” rating in a research report on Friday, October 24th. Stephens reiterated an “outperform” rating on shares of Albemarle in a research report on Friday, December 19th. Citigroup upped their price target on shares of Albemarle from $180.00 to $190.00 and gave the stock a “neutral” rating in a research report on Friday. Finally, Scotiabank upgraded Albemarle from a “sector perform” rating to a “sector outperform” rating and lifted their price objective for the stock from $85.00 to $200.00 in a report on Monday, January 12th. Three equities research analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating, eleven have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $162.72.

Albemarle Stock Performance

Shares of Albemarle stock opened at $166.42 on Monday. The business’s 50 day moving average price is $158.16 and its 200 day moving average price is $115.66. The company has a market cap of $19.61 billion, a price-to-earnings ratio of -28.94, a PEG ratio of 2.40 and a beta of 1.44. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.57 and a current ratio of 2.23. Albemarle Corporation has a one year low of $49.43 and a one year high of $195.68.

Albemarle (NYSE:ALB) last issued its earnings results on Wednesday, February 11th. The specialty chemicals company reported ($0.53) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.40) by ($0.13). The company had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.34 billion. Albemarle had a positive return on equity of 0.41% and a negative net margin of 10.74%.The firm’s revenue was up 15.9% compared to the same quarter last year. During the same period last year, the business earned ($1.09) earnings per share. On average, research analysts predict that Albemarle Corporation will post -0.04 EPS for the current year.

Key Stories Impacting Albemarle

Here are the key news stories impacting Albemarle this week:

• Positive Sentiment: Revenue beat and strong Energy Storage demand — Q4 revenue topped estimates with ~16% y/y growth driven by Energy Storage volumes and pricing, a primary reason bulls cite for upside in ALB. ALB Q4 Earnings Miss, Revenues Beat on Higher Volumes & Pricing
• Positive Sentiment: Raised FY‑2026 revenue guidance — management issued a FY‑26 revenue range (~$5.7B–$6.0B) above consensus, giving investors a forward revenue anchor amid lithium price swings. Is Albemarle Setting Up for a Lithium-Fueled Rebound?
• Positive Sentiment: Analyst upside moves — Morgan Stanley and Mizuho raised price targets (to $170 and $185 respectively), signaling some sell‑side conviction on medium-term fundamentals. Morgan Stanley raises price target on Albemarle Mizuho raises price target on Albemarle
• Positive Sentiment: U.S. production support and grants — company commentary and coverage highlight DOE support (Kings Mountain reactivation) and domestic production steps that improve supply‑chain optionality. Is Albemarle Setting Up for a Lithium-Fueled Rebound?
• Neutral Sentiment: Earnings call tone — management emphasized cash strength, disciplined capacity management and flexibility across cycles; those points reduce tail‑risk but leave near‑term volatility intact. Albemarle Earnings Call: Cash Strength Amid Lithium Cycles Albemarle Q4 2025 Earnings Call Transcript
• Positive Sentiment: Potential policy tailwinds — the House passed H.R.3617 (Securing America’s Critical Minerals Supply Act), which could support domestic critical‑minerals investment over time. Congress Vote: The House has passed H.R.3617
• Negative Sentiment: EPS miss and wider loss — Albemarle reported a larger-than-expected Q4 loss (missed EPS estimates), a headline that keeps short-term sellers active. ALB Q4 Earnings Miss, Revenues Beat on Higher Volumes & Pricing
• Negative Sentiment: Not all analysts are bullish — JPMorgan cut its price target to $145 (neutral), a headline that can cap near‑term upside. JPMorgan adjusts price target on Albemarle to $145 from $195
• Negative Sentiment: Macro and lithium price volatility — broader market rate/volatility concerns and swings in lithium prices mean ALB can move sharply both ways; expect continued choppy trading. MarketBeat Week in Review

Albemarle Company Profile

Albemarle Corporation is a leading global specialty chemicals company primarily engaged in the production and distribution of lithium, bromine, and catalysts. Its lithium segment supplies key components used in rechargeable batteries for electric vehicles, portable electronics, and grid storage systems. The company’s bromine specialty products serve a wide range of industries, including oil and gas drilling fluids, fire safety solutions, and water treatment. In its catalysts division, Albemarle provides products for petroleum refining, chemical processing and emissions control.

Founded in 1994 as a spin-off from Ethyl Corporation, Albemarle has grown through strategic acquisitions and capacity expansions to become one of the world’s foremost chemical producers.